In the highest-risk groups, roughly one in 12 people developed depression over the next 10 years
GLP-1 receptor agonists are associated with improvements in restrained eating, emotional eating behavior, QOL
Findings show changes in specific regions of the brain
However, increased risk of self-harm is seen before initiation of treatment, during initial phase of treatment, and after discontinuation
No protective associations seen for time outdoors, but protective effects for participation in organized sports
More than 60 percent had pathological fatigue at baseline, persisting in 53.8 percent at 12 months
Most individuals report that their first opioid exposure involved prescription opioids for themselves or others
Newly developed patient-centered measure reveals distress among patients
Differences in social media use also seen by condition type